NTHI
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ: NTHI · HEALTHCARE · BIOTECHNOLOGY
$5.45
-16.02% today
Updated 2026-05-08
Market cap
$137.81M
P/E ratio
—
P/S ratio
3,446.01x
EPS (TTM)
$-3.20
Dividend yield
—
52W range
$3 – $13
Volume
0.1M
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-396693.00 | $-881736.00 | $-1.88M | $-4.21M | $-20.36M |
| Capital expenditures | $3.00 | $4.00 | $0.00 | $4.00 | $500000.00 |
| Depreciation | — | — | $0.00 | $245945.00 | — |
| Stock-based comp | $2.22M | $1.29M | $0.00 | $0.00 | $35.56M |
| Free cash flow | $-396696.00 | $-881740.00 | $-1.88M | $-4.21M | $-20.86M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | $250000.00 | $1.49M | $1.28M | $4.25M | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |